RGD DISEASE ONTOLOGY - ANNOTATIONS
RGD uses the Human Disease Ontology (DO, https://disease-ontology.org/) for disease curation across species. RGD automatically downloads each new release of the ontology on a monthly basis. Some additional terms which are required for RGD's curation purposes but are not currently covered in the official version of DO have been added. As corresponding terms are added to DO, these custom terms are retired and the DO terms substituted in existing annotations and subsequently used for curation.
Term: sickle cell disease
Accession: DOID:0081445
browse the term
Definition: A blood protein disease that is characterized by chronic hemolytic anemia and intermittent vaso-occlusive events that result in tissue ischemia leading to acute and chronic pain as well as organ damage that can affect any organ system, resulting from the replacement of one of the beta-globin subunits in hemoglobin with atypical hemoglobin molecules called hemoglobin S which can distort red blood cells into a sickle or crescent shape. Sickle cell disease subtypes should include a detailed genotypic description for the hemoglobin molecules (e.g., Hb S/S, Hb S/C, Hb S/β0-thalassemia). (DO)
Synonyms: xref: MIM:603903
G
HMOX1
heme oxygenase 1
ISO
associated with Anemia, Sickle Cell;DNA:repeat:promoter
RGD
PMID:22966170
RGD:10755560
G
NOS3
nitric oxide synthase 3
susceptibility
ISO
associated with Anemia, Sickle Cell;DNA:polymorphism: :-786T>C(human) associated with Anemia, Sickle Cell;DNA:repeats:intron:
RGD
PMID:14687036 PMID:25263931
RGD:11533931 RGD:11533934
NCBI chr18:6,209,218...6,228,912
Ensembl chr18:6,209,158...6,228,943
G
VEGFA
vascular endothelial growth factor A
susceptibility
ISO
associated with Anemia, Sickle Cell;DNA:SNPs: : rs2010963, rs833068,rs3025020(human) associated with Anemia, Sickle Cell;DNA:polymorphism:583C > T (human)
RGD
PMID:22925497 PMID:25130874
RGD:11075233 RGD:11075235
NCBI chr 7:38,746,393...38,762,282
Ensembl chr 7:38,746,052...38,761,366
G
ALAD
aminolevulinate dehydratase
ISO
protein:increased activity:erythrocyte
RGD
PMID:900140
RGD:12904674
NCBI chr 1:254,015,426...254,027,584
Ensembl chr 1:254,012,850...254,027,508
G
APOB
apolipoprotein B
treatment
ISO
RGD
PMID:24035168
RGD:11354943
NCBI chr 3:117,250,096...117,316,200
Ensembl chr 3:117,250,096...117,316,200
G
BCL11A
BCL11 transcription factor A
treatment severity
ISO
DNA:snp, haplotype:intron:c.386-24983T>C (rs4671393) (human)
RGD
PMID:18667698 PMID:21998251 PMID:22360576
RGD:11099970 RGD:11099996 RGD:11100007
NCBI chr 3:81,195,217...81,296,165
Ensembl chr 3:81,196,294...81,296,382
G
C3
complement C3
severity
ISO
protein:increased processing
RGD
PMID:3896597 PMID:7554454
RGD:11040773 RGD:11040777
NCBI chr 2:72,431,470...72,471,622
Ensembl chr 2:72,431,212...72,472,228
G
CAD
carbamoyl-phosphate synthetase 2, aspartate transcarbamylase, and dihydroorotase
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:38827
NCBI chr 3:111,887,017...111,914,511
Ensembl chr 3:111,887,020...111,914,492
G
CD36
CD36 molecule
treatment
ISO
protein:increased expression:erythrocyte
RGD
PMID:18322255 PMID:20015873
RGD:11041114 RGD:6893506
NCBI chr 9:99,685,748...99,782,296
Ensembl chr 9:99,605,181...99,782,105
G
CD40LG
CD40 ligand
ISO
protein:increased expression:plasma (human)
RGD
PMID:24368019
RGD:11352270
NCBI chr X:111,778,666...111,788,901
Ensembl chr X:111,778,493...111,789,709
G
CFB
complement factor B
ISO
protein:decreased activity
RGD
PMID:10440069 PMID:12793071
RGD:11041159 RGD:11041160
NCBI chr 7:24,034,077...24,040,523
Ensembl chr 7:24,033,740...24,041,179
G
CYP2C49
cytochrome P450 2C49
susceptibility
ISO
DNA:polymorphisms: :c.681 G>A,wildtype(human)
RGD
PMID:20831548
RGD:11352749
NCBI chr14:106,571,803...106,612,082
Ensembl chr14:106,285,173...106,612,455
G
DHODH
dihydroorotate dehydrogenase (quinone)
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:38827
NCBI chr 6:14,942,898...14,956,000
Ensembl chr 6:14,942,933...14,955,997
G
F2
coagulation factor II, thrombin
disease_progression
ISO
protein:increased expression:plasma:
RGD
PMID:8191393 PMID:26286849
RGD:11565074 RGD:11565080
NCBI chr 2:15,793,257...15,819,151
Ensembl chr 2:15,791,455...15,819,137
G
F3
coagulation factor III, tissue factor
ISO
protein:increased expression:plasma
RGD
PMID:15795541
RGD:11341683
NCBI chr 4:122,827,018...122,837,673
Ensembl chr 4:122,826,644...122,837,666
G
GCH1
GTP cyclohydrolase 1
sexual_dimorphism
ISO
DNA:SNP, haplotype:rs8007267 (human)
RGD
PMID:24136375
RGD:329961567
NCBI chr 1:184,201,232...184,264,060
Ensembl chr 1:184,199,679...184,257,315
G
GPX1
glutathione peroxidase 1
treatment
ISO
protein:decreased expression:penis
RGD
PMID:19951064 PMID:20846340 PMID:22620981
RGD:11352756 RGD:11352757 RGD:11352775
NCBI chr13:31,916,269...31,917,337
Ensembl chr13:31,916,246...31,917,433
G
GSR
glutathione-disulfide reductase
ISO
protein:increased activity:erythrocyte:
RGD
PMID:14717789
RGD:11059503
NCBI chr15:54,382,564...54,433,989
Ensembl chr15:54,382,567...54,433,984
G
HBE1
hemoglobin subunit epsilon 1
treatment
ISO
DNA:SNP: :rs7130110 (human)
RGD
PMID:12124399 PMID:23409025
RGD:11353858 RGD:11353860
NCBI chr 9:4,818,206...4,820,243
Ensembl chr 9:4,817,748...4,820,243
G
HK1
hexokinase 1
ISO
protein:alternative form:erythrocyte
RGD
PMID:5686464
RGD:11353884
NCBI chr14:72,383,328...72,460,927
Ensembl chr14:72,351,246...72,460,924
G
HMBS
hydroxymethylbilane synthase
ISO
protein:increased activity:erythrocyte
RGD
PMID:900140
RGD:12904674
NCBI chr 9:46,300,039...46,308,681
Ensembl chr 9:46,300,050...46,308,868
G
HMOX1
heme oxygenase 1
treatment
ISO
RGD
PMID:11238038 PMID:20306336
RGD:10755563 RGD:10755565
G
HP
haptoglobin
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:16597321
NCBI chr 6:14,980,382...14,985,245
G
IL10
interleukin 10
treatment
ISO
RGD
PMID:24281564
RGD:11046271
NCBI chr 9:67,400,727...67,405,941
Ensembl chr 9:67,400,728...67,405,378
G
IL5
interleukin 5
ISO
protein:increased expression:respiratory system fluid/secretion
RGD
PMID:25843670
RGD:11354938
NCBI chr 2:134,832,143...134,846,141
Ensembl chr 2:134,832,147...134,835,212
G
MDM2
MDM2 proto-oncogene
ISO
RGD
PMID:21085184
RGD:10412315
NCBI chr 5:33,105,717...33,137,602
Ensembl chr 5:33,105,759...33,137,739
G
MTHFR
methylenetetrahydrofolate reductase
no_association severity
ISO
DNA:SNP: :677C>T (human) DNA:SNP: :1298A>C (human)
RGD
PMID:20113291 PMID:22924497
RGD:10449403 RGD:10449420
NCBI chr 6:71,863,637...71,882,118
Ensembl chr 6:71,863,637...71,881,820
G
NFE2L2
NFE2 like bZIP transcription factor 2
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:29255069
NCBI chr15:82,967,485...83,146,185
Ensembl chr15:82,973,656...83,146,183
G
NOS3
nitric oxide synthase 3
severity
ISO
DNA:polymorphisms,haplotype:intron,cds:894G>T, -786T>C(human)
RGD
PMID:24088668
RGD:11533647
NCBI chr18:6,209,218...6,228,912
Ensembl chr18:6,209,158...6,228,943
G
NPPB
natriuretic peptide B
severity
ISO
CTD Direct Evidence: marker/mechanism
CTD RGD
PMID:20408845 PMID:21689089
RGD:5685653
NCBI chr 6:71,930,374...71,931,843
Ensembl chr 6:71,930,382...71,932,254
G
PECAM1
platelet and endothelial cell adhesion molecule 1
severity
ISO
protein:increased expression:serum (human)
RGD
PMID:20306667
RGD:11541101
NCBI chr12:14,667,643...14,723,296
Ensembl chr12:14,649,044...14,723,293
G
PGF
placental growth factor
ISO
protein:increased expression:plasma
RGD
PMID:20040765
RGD:6483588
NCBI chr 7:98,149,510...98,162,784
Ensembl chr 7:98,148,994...98,162,741
G
PON1
paraoxonase 1
ISO
protein:decreased activity: serum (human)
RGD
PMID:24508012
RGD:11553835
NCBI chr 9:74,943,646...74,974,720
Ensembl chr 9:74,926,048...74,974,723
G
SELP
selectin P
ISO
RGD
PMID:21071696
RGD:6219007
NCBI chr 4:81,376,804...81,401,240
Ensembl chr 4:81,365,740...81,399,955
G
SPTA1
spectrin alpha, erythrocytic 1
ISO
OMIM:603903
MouseDO
NCBI chr 4:91,573,470...91,640,057
Ensembl chr 4:91,485,067...91,640,063
G
TGFB1
transforming growth factor beta 1
ISO
protein:increased expression:plasma:
RGD
PMID:26928604
RGD:11062147
NCBI chr 6:49,332,169...49,348,642
Ensembl chr 6:49,332,173...49,349,046
G
TNF
tumor necrosis factor
ISO
CTD Direct Evidence: marker/mechanism protein:increased expression:serum
CTD RGD
PMID:8140855 PMID:14965870
RGD:10449460
NCBI chr 7:23,699,635...23,702,393
Ensembl chr 7:23,699,628...23,702,416
G
UMPS
uridine monophosphate synthetase
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:38827
NCBI chr13:135,611,857...135,650,656
Ensembl chr13:135,610,058...135,650,603
G
VCAM1
vascular cell adhesion molecule 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:16916123
NCBI chr 4:117,496,914...117,511,211
Ensembl chr 4:117,496,920...117,511,222
G
SERPINF1
serpin family F member 1
ISO
protein:increased expression:retinal blood vessels (human)
RGD
PMID:12957143
RGD:8554869
NCBI chr12:47,949,004...47,959,471
Ensembl chr12:47,948,510...47,959,470
G
HP
haptoglobin
ISO
RGD
PMID:19023114 PMID:21595649
RGD:5147416 RGD:5147440
NCBI chr 6:14,980,382...14,985,245
G
MBL2
mannose binding lectin 2
susceptibility
ISO
associated with Anemia, Sickle Cell;DNA:promoter,exon:
RGD
PMID:20172753
RGD:11530044
NCBI chr14:97,103,926...97,107,635
Ensembl chr14:97,102,823...97,108,083
G
NOS3
nitric oxide synthase 3
susceptibility
ISO
associated with Anemia, Sickle Cell;DNA:repeats:intron:
RGD
PMID:25263931
RGD:11533931
NCBI chr18:6,209,218...6,228,912
Ensembl chr18:6,209,158...6,228,943
G
PDE9A
phosphodiesterase 9A
treatment
ISO
RGD
PMID:22833547
RGD:242905184
NCBI chr13:205,938,342...206,034,981
Ensembl chr13:205,938,348...206,034,976
G
SLC4A1
solute carrier family 4 member 1
ISO
RGD
PMID:23643401
RGD:11100023
NCBI chr12:18,957,813...18,975,266
Ensembl chr12:18,957,807...18,974,208
Term paths to the root one shortest all shortest one longest all longest one shortest and longest all